For healthier and more sustainably produced food
News
11/12/24 8:46 AM
c-LEcta's NuCLEANase Receives Positive GRAS Evaluation from US FDA
After submitting a GRAS notification for NuCLEANase (GRN No.1146) to the US FDA, c-LEcta has received a positive evaluation with no questions from.
read more
9/17/24 8:31 AM
c-LEcta celebrates 20 years of innovation
The biotech pioneer celebrates with employees and guests with live music and a varied program.
read more
Unique technology platform
c-LEcta uses its proprietary technology platform ENESYZ to develop customized enzymes and microbial production strains that meet the requirements of a wide range of manufacturing processes in industry. It has been continuously improved since its foundation in 2004 and has repeatedly proven its efficiency.
Why with c-LEcta?
For more than 400 customers worldwide, we are a reliable supplier of biotechnologically manufactured products that meet the highest quality requirements.